A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets ...

Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.

Researchers examined disease-specific or interactive effects of parental severe mental disorders on psychiatric risk in offspring.

NEW YORK (AP) — Jon Stanley considers himself fortunate among bipolar disorder patients. He eventually responded to the right ...

A massive genetic analysis of more than 6 million people is revealing new clues about why mental health disorders frequently overlap.

For decades, scientists studying brain disorders have focused almost exclusively on proteins and the genes encoding them. Now ...

In this two-part episode, we explore the experience of living with bipolar disorder in recognition of World Bipolar Day on ...

Health Secretary Robert F. Kennedy Jr. recently said that the diet could “cure” schizophrenia. We asked experts about the claim.

Shares of Vanda Pharmaceuticals climbed after the company received approval from the Food and Drug Administration for its treatment of a type of bipolar disorder, as well as schizophrenia. The stock ...

Vanda Pharmaceuticals received approval from the Food and Drug Administration for its treatment of a type of bipolar disorder as well as schizophrenia. The biopharmaceutical company said Friday ...

WASHINGTON, Feb. 20, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a ...